Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 6/20 | 0.41 |
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | G6PD | P11413 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17091718 | 0.88 | ALDH1A1 (0.45) | ALDH1A1LGALS8G6PD | |
| SCHEMBL15463280 | 0.87 | ALDH1A1 (0.38) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL9610875 | 0.80 | CYP2D6 (0.46) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL9612321 | 0.80 | CYP2D6 (0.46) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL16744076 | 0.80 | LGALS8 (0.38) | LGALS8FGF1THRBG6PDCYP2D6 | |
| SCHEMBL9610882 | 0.80 | CYP2D6 (0.46) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL15926260 | 0.80 | CYP2D6 (0.46) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL9612324 | 0.80 | CYP2D6 (0.46) | ALDH1A1LGALS8THRBCYP2D6HSD17B10 | |
| SCHEMBL27016383 | 0.77 | LGALS8 (0.44) | LGALS8G6PD | |
| SCHEMBL23380088 | 0.77 | ALDH1A1 (0.38) | ALDH1A1LGALS8THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160354504-A1 | MALODOR COUNTERACTING COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2016-12-08 | — | — | US | disclosed |
| US-20150147287-A1 | LOW VOLATILE REACTIVE MALODOR COUNTERACTIVES AND METHODS OF USE THEREOF | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2015-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160354504-A1 | MALODOR COUNTERACTING COMPOSITIONS | LPO, MAL2, ME1 | ALDH1A1 257/4885LGALS8 805/4885FGF1 3839/4885 |
| US-20150147287-A1 | LOW VOLATILE REACTIVE MALODOR COUNTERACTIVES AND METHODS OF USE THEREOF | LPO, TYR, MAL2 | ALDH1A1 94/4885LGALS8 841/4885FGF1 4742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.